- Lobbying
- Matthew AND Schwartz
Lobbying Arrangements Results for 'Matthew Schwartz'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Discussion on Future of TRICARE Program over coming years |
Health Net Federal Services
|
in-house lobbying | |||
Details Advice and assistance with fair trade policy and related issues. |
Noranda Aluminum, Inc.
|
Thompson Hine LLP | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Providing advice, counsel, and services to support the Pharma & Biopharma Outsourcing Association's public policy priorities |
Pharma & Biopharma Outsourcing Association
|
BGR Government Affairs | |||
Details Provide guidance and strategic advice regarding FDA regulation of medical devices, including diagnostic tests |
Advanced Medical Technology Association
|
BGR Government Affairs | |||
Details Administrative and congressional outreach and monitoring on issues related to the EB-5 investor program. Monitor administrative action on DHS/USCIS Rule (RIN 1615-AC07), Improvement of the Employm... |
Related Fund Management
|
GREENBERG TRAURIG, LLP | |||
Details Legislation and regulations affecting the long-term care pharmacy industry |
Senior Care Pharmacy Coalition
|
BGR Government Affairs | |||
Details Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry |
Walgreen Co.
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC specifically. |
PTC Therapeutics
|
BGR Government Affairs | |||
Details Provide strategic counsel and policy analysis related to federal payment and policy issues and government funding impacting hospitals generally and Mass General Brigham specifically |
MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE)
|
BGR Government Affairs | |||
Details Provide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue |
Edward Lifesciences LLC
|
BGR Government Affairs | |||
Details Strategic advice and counsel on issues impacting gene and cell therapy development and access |
American Society of Gene and Cell Therapy
|
BGR Government Affairs | |||
Details Provide lobbying support on key issues and providing intelligence and policy tracking for relevant federal policy developments that could impact the pharmaceutical and medical device industry gener... |
Bayer Corporation
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Horizon specifically. |
Horizon Pharma
|
BGR Government Affairs | |||
Details Strategic guidance and counsel on maintaining and strengthening the employer-based health care system, and advise the client on legislative and regulatory issues. |
Lockton Management, LLC
|
BGR Government Affairs | |||
Details Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration. |
Pharmaceutical Research and Manufacturers of America
|
BGR Government Affairs | |||
Details Strategic guidance and advocacy on health care related issues to include: healthcare reform, HIV/AIDS, bio-defense, Medicare/Medicaid and FDA |
GlaxoSmithKline, INC
|
BGR Government Affairs | |||
Details Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Ca... |
Amgen Inc.
|
BGR Government Affairs | |||
Details Provide guidance and counsel with regard to federal medical device policy and regulatory issues and reimbursement issues within Medicare program, including IPPS Regulation, and FDA regulatory policy. |
Abiomed Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy |
Neurocrine Biosciences, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact nonprofit initiatives generally, patient assistance initiatives, rare disease patients and The Assistance ... |
The Assistance Fund
|
BGR Government Affairs | |||
Details Advise and advocate on client's behalf regarding ongoing public policy concerns impacting the innovative biotechnology industry in Congress and throughout the Administration |
Biotechnology Innovation Organization
|
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the medical device industry generally, and Stryker Corporation specifically. |
Stryker Corporation
|
BGR Government Affairs | |||
Details Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum - to include 5G. Data rights issues. FY24 NASA Authorization legislation. FY24 CJS Appropriations. ... |
BOEING COMPANY
|
in-house lobbying | |||
Details Health care issues including Medicare's long-term financial health and drivers of health insurance premium changes, and comments on proposed legislation to add a long-term care benefit to the Medic... |
American Academy of Actuaries
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 4664/S. 2309, Financial Services and General Government Appropriations Act, 2024 H.R. 4763, Financial Innovation and ... |
MANAGED FUNDS ASSOCIATION
|
in-house lobbying | |||
Details Protect the credit union tax exemption; Support legislation and regulation that helps credit unions grow membership, loans, and retained earnings in order to serve their 138 million members; Supp... |
National Association of Federally-Insured Credit Unions
|
National Association of Federally-Insured Credit Unions (FKA Nat'l Assn of Federal Credit Unions) | |||
Details AD&C Lending, FHA Reform, Affordable Housing Reform, GSE Reform, Corporate Transparency Act of 2019, Violence Against Women Act, Dodd-Frank Reform Interior and Environment Appropriations, Energy an... |
National Association of Home Builders
|
in-house lobbying | |||
Details HR 5433- Child Care Stabilization Act HR 5569, S 3294- Child Care Nutrition Enhancement Act HR 6067- Early Childhood Nutrition Improvement Act Farm Bill Farm Bill- Puerto Rico NAP to SNAP HR 5094- ... |
AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES
|
in-house lobbying | |||
Details LGBTQ+ Non-Discrimination LGBTQ Data Collection DC Statehood Violence Against LGBTQ+ Community Anti-LGBTQ+ Riders in Appropriations Bills Bans on Drag Performance Bans on Pride Flags Workplace Di... |
HUMAN RIGHTS CAMPAIGN
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying |